Online retailer Vapkit has launched a quit smoking service called Get Healthy Rotherham, which aims to help 39,487 smokers quit traditional cigarettes. The company's research found that the North of England is one of the worst areas in the UK for smokers to access local support to quit.
According to a study by Vapekit, England has nearly 500,000 adult smokers who are unable to access local support services to quit smoking. The Rotherham area is among the worst, with only one service available to help almost 40,000 smokers.
Negative news reports have rocked the local council and the Rotherham NHS Foundation Trust Fund. The Director of Public Health for Rotherham stated that throughout the year, the committee has been engaging with residents to promote healthier lifestyles and providing advice on quitting smoking through existing services. Over the past few years, the hard work of Rotherham Hospital's maternity ward has resulted in a remarkable increase in the number of pregnant mothers who have quit smoking.
It is important to understand that quitting smoking is a very personal process for many people. Some may use over-the-counter nicotine products and e-cigarettes to quit, while others have found success with online support such as the NHS quit smoking app.
The Rothwell NHS Foundation Trust has announced that it is fully committed to helping smokers quit and has recently added outpatient patients to its list of potential clients.
A spokesperson for the Department of Health and Social Care told Rothwell Advertisers, "Tackling smoking is a key part of the government's agenda and that's why we've launched an independent review of the England Tobacco Control Plan 2030.
According to a comprehensive study by Vapekit, the cities in the UK with the highest number of adult smokers often have the worst smoking cessation support services. A spokesperson for Vapekit stated that "quitting smoking remains the only preventable cause of death in the UK, resulting in approximately 78,000 fatalities annually. The NHS spends £3.6 billion on medical and social care, with an estimated social cost of £17 billion - £5 billion more than previously calculated - due to individuals who have died from smoking-related diseases, such as cancer, being unable to work.
Statement:
This article is compiled from third-party information and is intended for industry communication and learning purposes.
This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness or accuracy of the article's content. The translation of this article is solely for communication and research purposes within the industry.
Due to limitations in translation ability, the translated article may not fully reflect the same meaning as the original. Please refer to the original text for accuracy.
2FIRSTS maintains full alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and foreign-related expressions and positions.
The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
